Apply on Employer Site

CSL · 16 hours ago

Senior Director, Early Partnerships Lead

Greater Boston

Full-time

Hybrid

Director/Executive

12+ years exp

CSL is a biotech company focused on delivering innovative therapies for patients. They are seeking a Senior Director, Early Partnerships Lead to drive strategic sourcing and evaluation of external innovation opportunities in various therapeutic areas, while leading cross-functional teams and executing early partnering strategies.

BiotechnologyHealth CareHealth DiagnosticsMedical

Comp. & Benefits

Hiring Manager

Jamie O'Malley

Responsibilities

Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy

Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within each CSL’s therapeutic areas. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations

Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets

Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions

Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution

Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities

Qualification

Biopharma experienceExternal innovationBusiness developmentScientific expertiseDue diligenceAdvanced degreeNetworking

Required

12+ years in biopharma with significant experience in external innovation, search & evaluation, or business development

Advanced degree required (PhD, MD, or equivalent)

Deep scientific expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas

Proven track record of leading due diligence and closing early-stage deals

Strong network within biotech, academia, and pharma BD organizations

Company

CSL

Glassdoor4.6

CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.

Founded in 1916

Melbourne, Victoria, AUS

10001+ employees

https://www.csl.com

Funding

Current Stage

Public Company

Total Funding

$111M

2013-12-20Acquired

2004-02-06Post Ipo Equity· $111M

1994-06-03IPO

Leadership Team

Jeffrey Ball

Chief Sustainability Officer

Joy Linton

Strategic Advisor

Recent News

Pharma Letter

MHRA approves Kostaive mRNA COVID-19 vaccine

2026-01-03

MarketScreener

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

2025-12-07

thefly.com

CSL just upgraded at Canaccord, here's why

2025-10-29

Company data provided by crunchbase